Drug Shortage Report for FENTANYL CITRATE INJECTION, USP
Report ID | 205907 |
Drug Identification Number | 02501554 |
Brand name | FENTANYL CITRATE INJECTION, USP |
Common or Proper name | FENTANYL CITRATE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | FENTANYL |
Strength(s) | 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR EPIDURAL |
Packaging size | 1 mL |
ATC code | N01AH |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-10-06 |
Actual start date | 2023-10-06 |
Estimated end date | 2023-11-15 |
Actual end date | 2023-11-15 |
Shortage status | Resolved |
Updated date | 2023-11-17 |
Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Fentanyl Citrate Injection, USP 50 mcg/mL 1 mL SD Vial effective October 6, 2023, until November 15, 2023. During this time, our Fentanyl Citrate Injection, USP 50 mcg/mL 2 mL SD Vial is available for substitution |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-11-17 | French | Compare |
v4 | 2023-11-17 | English | Compare |
v3 | 2023-10-07 | English | Compare |
v2 | 2023-10-03 | French | Compare |
v1 | 2023-10-03 | English | Compare |
Showing 1 to 5 of 5